BI
RGLS

BVF Inc’s Regulus Therapeutics RGLS Stock Holding History

BVF Inc’s Portfolio RGLS Stock Details RGLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-337,621
Closed -$4.56M – 72
2020
Q4 		$4.56M Buy
337,621
+15,873
+5% +$117K 0.18% 59
2020
Q3 		$1.65M Buy
321,748
+176,748
+122% +$1.16M 0.09% 60
2020
Q2 		$988K Sell
145,000
-14,292
-9% -$93.5K 0.06% 54
2020
Q1 		$734K Sell
159,292
-44,278
-22% -$386K 0.07% 54
2019
Q4 		$1.81M Hold
203,570
– – 0.14% 52
2019
Q3 		$1.47M Hold
203,570
– – 0.15% 54
2019
Q2 		$2.54M Buy
203,570
+98,376
+94% +$1.13M 0.28% 50
2019
Q1 		$1.07M Hold
105,194
– – 0.12% 51
2018
Q4 		$979K Sell
105,194
-8,849
-8% -$147K 0.13% 51
2018
Q3 		$2.7M Hold
114,043
– – 0.24% 51
2018
Q2 		$9.02M Sell
114,043
-2,409
-2% -$199K 0.88% 32
2018
Q1 		$10M Hold
116,452
– – 1.02% 28
2017
Q4 		$14.5M Buy
116,452
+8,542
+8% +$1.08M 1.75% 17
2017
Q3 		$16.2M Buy
107,910
+80,586
+295% +$10.1M 2.06% 18
2017
Q2 		$3.23M Buy
27,324
+22,132
+426% +$3.69M 0.5% 30
2017
Q1 		$1.03M Buy
+5,192
New +$988K 0.17% 30
2014
Q4 		– Sell
-1,542
Closed -$1.26M – 36
2014
Q3 		$1.26M Hold
1,542
– – 0.26% 26
2014
Q2 		$1.49M Hold
1,542
– – 0.24% 26
2014
Q1 		$1.67M Sell
1,542
-405
-21% -$449K 0.26% 24
2013
Q4 		$1.73M Hold
1,947
– – 0.3% 22
2013
Q3 		$2.2M Sell
1,947
-273
-12% -$322K 0.38% 24
2013
Q2 		$2.61M Buy
+2,220
New +$2.11M 0.51% 20

Other funds holding RGLS

NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
ACM
Asymmetry Capital Management San Francisco, California $188M AUM 44.72% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

BVF Inc's RGLS Position: Q1 2021 in Review

BVF Inc sold out of Regulus Therapeutics (RGLS) in Q1 2021, closing a stake of 337,621 shares — an estimated $4.56M sold.

BVF Inc first reported a position in RGLS in Q2 2013 and held it in 22 quarters. The position peaked at $16.2M in Q3 2017. 44 funds tracked by Wall St. Rank hold RGLS as of Q1 2021.

  • BVF Inc reported no remaining Regulus Therapeutics position as of Q1 2021 after selling out during the quarter.
  • BVF Inc sold 337,621 Regulus Therapeutics shares in Q1 2021, an estimated $4.56M.
  • BVF Inc first reported a position in Regulus Therapeutics in Q2 2013 and held it in 22 quarters.
  • BVF Inc's Regulus Therapeutics position peaked at $16.2M in Q3 2017.
  • 44 funds tracked by Wall St. Rank held Regulus Therapeutics as of Q1 2021.

Based on BVF Inc's 13F filing for Q1 2021, filed 17 May 2021.